About Us-BioQ Technology

Company Profile

BioQ, a biotechnology company affiliated with Guyu Biotechnology Group, specializes in the research, development, production, and sales of Chinese specialty botanical ingredients. With high-tech enterprise status, we excel at accurately screening raw materials based on market research, developing proprietary technologies and formulations, meticulously identifying product selling points, and conducting scientific efficacy evaluations. We then provide comprehensive, customized services through production and delivery.

BioQ draws inspiration from unique Chinese botanicals and utilizes advanced underlying technologies such as biosynthesis, plant extract purification, and chemical synthesis. These technologies are combined with patented melt crystallization, nano-encapsulation, and bio-enzyme conversion, along with deep insights into the practical needs of cosmetics and dietary supplements. We continuously develop a diverse range of effective ingredients.

Currently, BioQ has a mature product portfolio and application cases, establishing a strong R&D advantage.

First & Only

Chinese raw materials company featured in the international journal Nature
Led by academicians

With the support of academicians, we established a joint biotechnology research center with Xiamen University
Leading scientific research capabilities

Obtained 45 national invention patents and applied for 75 patents in total

Development History

Specializing in the efficacy and mechanism of action of glabridin

Specializing in the efficacy and mechanism of action of glabridin

Overcoming the solubility problem of glabridin

Obtained a patent for liposome encapsulation of glabridin, solving the application problem of glabridin being insoluble in water/oil

Conducting research on rare ginsenosides

Begins in-depth research on the active ingredients in rare ginsenosides

Patent transformation of glabridin research results

Continuously obtain multiple patents for glabridin, and research results continue to emerge

BioQ was established

Established ginseng R&D collaboration with the Chinese Academy of Sciences The laboratory was upgraded to a high-standard, modern BioQ R&D center, and the company established its own raw material factory for independent production.

Demonstrating the mechanism of ginsenoside CK

For the first time, the pathway of action of ginsenosides was clearly demonstrated, and proteomic spectral probe technology was used to identify the anti-aging target of rare ginsenoside CK.

Achieved breakthroughs in R&D and received recognition as a high-tech enterprise

Patents for 99% purification technology and 28-nanometer encapsulation technology were obtained; patents for the process of preparing ginsenoside CK were also obtained.

Commercialization boom period

Aiming at application fields such as daily chemicals, food, health products, and pharmaceuticals, a 2+6+N product matrix has been formed, with rapid performance growth.